NCT02436356View on ClinicalTrials.gov

New Tools for Assessing Fracture Risk

NATerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

May 23, 2018

Study Completion Date

November 8, 2018

Conditions
OsteoporosisFracture Risk Assessment
Interventions
DEVICE

Osteoprobe-Reference Point Indentation (RPI)

Diagnostic tool used for bone indentation to measure the ability of the tissue to resist microindentation (bone mineral strength).

RADIATION

Dual-energy X-ray absorptiometry (DXA) Scans

Assessment of Fracture Risk

RADIATION

MRI

Determines bound water and pore water of bone.

Trial Locations (1)

37232

Vanderbilt Univeristy Medical Center, Nashville

Sponsors

Collaborators (1)

ActiveLife Scientific
All Listed Sponsors
collaborator

ActiveLife Scientific

INDUSTRY

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT02436356 - New Tools for Assessing Fracture Risk | Biotech Hunter | Biotech Hunter